Reduction of hemorrhagic complications after non-focal renal biopsy with pre-procedure desmopressin administration
Key Points
The aim is to evaluate the effectiveness of desmopressin in preventing bleeding after non-focal renal biopsy.
Administered desmopressin (DDAVP) before the renal biopsy procedure.
Monitored patients for clinically significant bleeding post-biopsy.
Desmopressin administration significantly decreased the occurrence of hemorrhagic complications.
Supports the use of desmopressin as a prophylactic measure in renal biopsy.
Abstract
Routine DDAVP administration before NRFB significantly reduces clinically significant bleeding, supporting its potential role as a simple prophylactic strategy.